Device Endotherapy

Single Use Repositionable Clip

Payments companies reported to CMS as associated with Single Use Repositionable Clip. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$254Kassociated payments (2023-2025)
437clinicians with associated payments
5companies reporting

By year

2024 $97K
2025 $157K

Payments reported as associated with Single Use Repositionable Clip, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $212K
Colon & Rectal Surgery $28K
Urology $4,880
Internal Medicine $793
Nurse Anesthetist, Certified Registered $573
Surgery $474

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Single Use Repositionable Clip

These are the largest totals companies reported as associated with Single Use Repositionable Clip. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Joo Hwang Stanford, CA Gastroenterology (Internal Medicine) $34,588.70
Peter Draganov Gainesville, FL Gastroenterology (Internal Medicine) $17,494.61
Mouen Khashab Baltimore, MD Gastroenterology (Internal Medicine) $16,771.07
Dennis Yang Orlando, FL Gastroenterology (Internal Medicine) $16,311.76
Hiroyuki Aihara Boston, MA Gastroenterology (Internal Medicine) $15,972.09
Jennifer Davids Boston, MA Colon & Rectal Surgery $15,506.33
Olga Beresneva Boston, MA Colon & Rectal Surgery $12,882.41
Christopher Huang Boston, MA Gastroenterology (Internal Medicine) $11,185.08
Nikhil Kumta New York, NY Gastroenterology (Internal Medicine) $10,392.04
Mihir Wagh Aurora, CO Gastroenterology (Internal Medicine) $8,637.81

Prescribed Single Use Repositionable Clip?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.